(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.08%) $79.06
(0.31%) $1.938
(0.87%) $2 331.10
(0.72%) $26.94
(1.14%) $965.80
(0.00%) $0.933
(-0.03%) $11.03
(-0.08%) $0.798
(0.06%) $93.51
Live Chart Being Loaded With Signals
Essex Bio-Technology Limited, an investment holding company, develops, manufactures, distributes, and sells biopharmaceutical products in the People's Republic of China and internationally...
Stats | |
---|---|
आज की मात्रा | 72 000.00 |
औसत मात्रा | 122 051 |
बाजार मूल्य | 1.31B |
EPS | HKD0 ( 2023-08-16 ) |
अगली कमाई की तारीख | ( HKD0 ) 2024-05-28 |
Last Dividend | HKD0.0450 ( 2023-08-29 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 4.89 |
ATR14 | HKD0.0210 (0.93%) |
Essex Bio-Technology Ltd सहसंबंध
10 सबसे अधिक सकारात्मक सहसंबंध |
---|
10 सबसे अधिक नकारात्मक सहसंबंध |
---|
क्या आप जानते हैं?
कोरलेशन एक सांख्यिकीय माप है जो दो चरों के बीच संबंध का वर्णन करता है। यह -1 से 1 तक का होता है, जहाँ -1 एक पूर्ण नकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा कम होता है), 1 एक पूर्ण सकारात्मक कोरलेशन को दर्शाता है (जैसे ही एक चर बढ़ता है, दूसरा भी बढ़ता है) और 0 कोई कोरलेशन नहीं होता है (चरों के बीच कोई संबंध नहीं है)।
कोरलेशन किसी भी दो चरों के बीच संबंध का विश्लेषण करने के लिए इस्तेमाल किया जा सकता है, न कि केवल स्टॉक में। यह वित्तीय, अर्थशास्त्र, मनोविज्ञान और अन्य क्षेत्रों में आमतौर पर उपयोग किया जाता है।
Essex Bio-Technology Ltd वित्तीय
Annual | 2023 |
राजस्व: | HKD1.71B |
सकल लाभ: | HKD1.54B (90.20 %) |
EPS: | HKD0.480 |
FY | 2023 |
राजस्व: | HKD1.71B |
सकल लाभ: | HKD1.54B (90.20 %) |
EPS: | HKD0.480 |
FY | 2022 |
राजस्व: | HKD1.32B |
सकल लाभ: | HKD1.19B (90.26 %) |
EPS: | HKD0.390 |
FY | 2021 |
राजस्व: | HKD1.64B |
सकल लाभ: | HKD1.40B (85.23 %) |
EPS: | HKD0.600 |
Financial Reports:
No articles found.
Essex Bio-Technology Ltd Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0.0400 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.0250 (N/A) |
HKD0.0450 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.0100 | 2009-04-30 |
Last Dividend | HKD0.0450 | 2023-08-29 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 21 | -- |
Total Paid Out | HKD0.602 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 3.59 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.26 | |
Div. Directional Score | 9.61 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9919.HK | Ex Dividend Knight | 2023-08-24 | Semi-Annually | 0 | 0.00% | |
2169.HK | Ex Dividend Junior | 2023-06-20 | Annually | 0 | 0.00% | |
1171.HK | Ex Dividend Knight | 2023-07-05 | Annually | 0 | 0.00% | |
0251.HK | Ex Dividend Junior | 2023-09-20 | Semi-Annually | 0 | 0.00% | |
3877.HK | Ex Dividend Junior | 2023-06-28 | Semi-Annually | 0 | 0.00% | |
1739.HK | No Dividend Player | 2023-09-05 | Sporadic | 0 | 0.00% | |
0778.HK | Ex Dividend Junior | 2023-08-23 | Semi-Annually | 0 | 0.00% | |
2331.HK | Ex Dividend Junior | 2023-08-23 | Sporadic | 0 | 0.00% | |
1308.HK | Ex Dividend Knight | 2023-08-28 | Semi-Annually | 0 | 0.00% | |
0369.HK | Ex Dividend Junior | 2023-09-14 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.161 | 1.500 | 6.77 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0973 | 1.200 | 6.76 | 8.11 | [0 - 0.3] |
returnOnEquityTTM | 0.148 | 1.500 | 9.47 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.145 | -1.000 | 8.55 | -8.55 | [0 - 1] |
currentRatioTTM | 1.536 | 0.800 | 7.32 | 5.86 | [1 - 3] |
quickRatioTTM | 1.425 | 0.800 | 6.32 | 5.06 | [0.8 - 2.5] |
cashRatioTTM | 0.633 | 1.500 | 7.59 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0968 | -1.500 | 8.39 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 21.84 | 1.000 | 3.02 | 3.02 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.588 | 2.00 | 9.80 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.363 | 2.00 | 9.82 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.142 | -1.500 | 9.43 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.902 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.185 | 1.000 | 8.29 | 8.29 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 1.220 | 1.000 | 4.33 | 4.33 | [0.2 - 2] |
assetTurnoverTTM | 0.604 | 0.800 | 9.31 | 7.45 | [0.5 - 2] |
Total Score | 12.97 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 4.74 | 1.000 | 9.62 | 0 | [1 - 100] |
returnOnEquityTTM | 0.148 | 2.50 | 9.66 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.363 | 2.00 | 9.88 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.04 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.588 | 2.00 | 9.80 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.145 | 1.500 | 8.55 | -8.55 | [0 - 1] |
pegRatioTTM | 0.0364 | 1.500 | -3.09 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.196 | 1.000 | 7.61 | 0 | [0.1 - 0.5] |
Total Score | 6.26 |
Essex Bio-Technology Ltd
Essex Bio-Technology Limited, an investment holding company, develops, manufactures, distributes, and sells biopharmaceutical products in the People's Republic of China and internationally. The company operates through Ophthalmic Products and Surgical Products segments. It researches and develops basic fibroblast growth factor products for the treatment of cellular proliferation, differentiation, and migration. The company offers Beifushu series, such as Beifushu eye drops, Beifushu eye gel, and Beifushu unit-dose eye drops; Tobramycin eye drops, Levofloxacin eye drops, and Sodium Hyaluronate eye drops, as well as Iodized Lecithin Capsules. It also provides Beifuji sprays and lyophilized powder, and Beifuxin gels for use in burn and scald wounds, acute wounds, surgical incisions, chronic wounds, skin grafting, and other applications. In addition, it offers ophthalmic and surgical products from third parties. Further, the company offers Carisolv dental caries removal gel; and Yi Xue An Granules. It has license agreements with Mitotech S.A. and Mitotech LLC. The company was founded in 1990 and is headquartered in Zhuhai, China.
के बारे में लाइव सिग्नल्स
इस पृष्ठ पर प्रस्तुत लाइव सिग्नल्स NA को कब खरीदना या बेचना है, इसका निर्धारण करने में मदद करते हैं। सिग्नल्स में 1-मिनट की देरी हो सकती है; सभी बाजार सिग्नल्स की तरह, त्रुटि या गलतियों की संभावना होती है।
लाइव ट्रेडिंग सिग्नल्स स्थायी नहीं हैं, और getagraph.com इन सिग्नल्स पर किए गए किसी भी कार्रवाई के लिए जिम्मेदारी नहीं रखते हैं, जैसा कि उपयोग की शर्तें में वर्णित है। सिग्नल्स एक व्यापक श्रृंखला के तकनीकी विश्लेषण संकेतकों पर आधारित हैं